Healthcare -
Biotechnology - NASDAQ - US
$ 5.44
2.84 %
$ 350 M
Market Cap
-5.49
P/E
CRVS - FREE CASH FLOW
Free Cash Flow CRVS - Corvus Pharmaceuticals, Inc.
-24 M
LAST VALUE
19.21%
2 YEAR CAGR
10.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR